Odyssey Therapeutics

Last updated: March 04, 2024

Gary Glick, CEO
Gary Glick, CEO
Country: USA | Funding: $487M (+)

Website: https://www.odysseytherapeutics.com

Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.